Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alba Guglielmo

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 8, 2022
Seroconversion and neutralizing antibodies production after completion of Pfizer-BioNTech BNT 162b2 vaccination scheme among psoriatic patients receiving biological or topical treatment: A prospective observational cohort studyGiuseppe Stinco, Enzo Errichetti, Matteo Figini, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 4, 2025
Mogamulizumab-induced alopecia. Multicentric case series: Clinical, trichoscopic and histological characterizationRaquel Cavestany Rodríguez, Daniel Falkenhain López, Pablo L Ortiz-Romero, et al.
The Journal of Investigative Dermatology|November 9, 2020
Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary SyndromePietro Quaglino, Paolo Fava, Alessandro Pileri, et al.
International Angiology : a Journal of the International Union of Angiology|May 12, 2022
Guidelines for Vascular Anomalies by the Italian Society for the study of Vascular Anomalies (SISAV)Francesco Stillo, Raul Mattassi, Andrea Diociaiuti, et al.
Clinical and Experimental Dermatology|October 30, 2025
Psoriasis and Seronegative Spondyloarthropathy in Atopic Dermatitis Patients Treated with Dupilumab or Tralokinumab: A Multicentre Observational StudyGiuseppe Lauletta, Cataldo Patruno, Luca Potestio, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 23, 2025
Effectiveness and safety of baricitinib in severe alopecia areata: 48-week resultsBianca Maria Piraccini, Stephano Cedirian, Francesca Pampaloni, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 8, 2022
Seroconversion and neutralizing antibodies production after completion of Pfizer-BioNTech BNT 162b2 vaccination scheme among psoriatic patients receiving biological or topical treatment: A prospective observational cohort studyGiuseppe Stinco, Enzo Errichetti, Matteo Figini, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 4, 2025
Mogamulizumab-induced alopecia. Multicentric case series: Clinical, trichoscopic and histological characterizationRaquel Cavestany Rodríguez, Daniel Falkenhain López, Pablo L Ortiz-Romero, et al.
The Journal of Investigative Dermatology|November 9, 2020
Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary SyndromePietro Quaglino, Paolo Fava, Alessandro Pileri, et al.
International Angiology : a Journal of the International Union of Angiology|May 12, 2022
Guidelines for Vascular Anomalies by the Italian Society for the study of Vascular Anomalies (SISAV)Francesco Stillo, Raul Mattassi, Andrea Diociaiuti, et al.
Clinical and Experimental Dermatology|October 30, 2025
Psoriasis and Seronegative Spondyloarthropathy in Atopic Dermatitis Patients Treated with Dupilumab or Tralokinumab: A Multicentre Observational StudyGiuseppe Lauletta, Cataldo Patruno, Luca Potestio, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 23, 2025
Effectiveness and safety of baricitinib in severe alopecia areata: 48-week resultsBianca Maria Piraccini, Stephano Cedirian, Francesca Pampaloni, et al.
Pageof 7